Kaust has entered into three strategic MOUs with leading Italian academic and industrial institutions, as well as a new joint scholarship program. These collaborations prove beneficial for international partnerships that support the Kingdom’s scientific and economic transformation. 

With a massive investment of 2 billion dollars, Astrazeneca has plans to expand its manufacturing footprint in Maryland, USA. This includes a significant expansion of its flagship biologics manufacturing facility in Frederick and construction of a new state-of-the-art facility in Gaithersburg for the development and clinical supply of innovative molecules to be used in clinical trials.

A new study using AI and satellite radar data shows that strongly protected marine areas are largely free from industrial fishing. The findings suggest that no-take zones are more effective than previously thought, offering a promising tool for ocean conservation and supporting global biodiversity targets.

The Orion project is part of the flagship initiative, ‘Artificial Intelligence in the Life Sciences, from a Human Health Perspective’ by Swiss Federal Innovation Agency Innosuisse. The goal of the research project is to help improve the treatment of each cancer patient.

Scientists have developed a new AI tool – iseg which has the capacity to not only match doctors in accurately outlining lung tumors on CT scans but can also identify areas that some doctors may miss.

An AI model developed by Johns Hopkins University outperforms doctors in predicting sudden cardiac death in patients with hypertrophic cardiomyopathy. By analysing heart MRIs and medical records, the system identifies high-risk individuals with up to 93 % accuracy.

Kaust and Aramco have entered into an intellectual property license agreement for commercialization of the Hybrid Unmanned Aerial Vehicle Crawler Technology. The technology boasts of merging aerial and terrestrial robotic capabilities to support inspection, monitoring, and other advanced industrial applications. 

A new study has revealed that artificial intelligence has the ability to detect and even interpret social situations between people from images and videos almost as reliably as humans.

Modern laboratory diagnostics is the first step toward successful patient treatment. During the MEDICA LABMED FORUM from November 17 to 20, experts will discuss what will shape laboratory medicine in the coming years.

Biophysicists have developed a new AI tool which has the capacity to identify gene combinations underlying complex illnesses like diabetes, cancer and asthma.